Datar Cancer Genetics Unveils Exacta AI: A Revolutionary AI-Driven Cancer Treatment Platform

Metropolis Healthcare Partners with Roche to Launch Self-Sampling HPV DNA Test for Cervical Cancer Screening in India

Union Budget 2025: Full Exemption from Basic Customs Duty (BCD) for 36 Lifesaving Drugs

Dr. Jitendra Singh Inaugurates Centre for Advanced Genomics & Precision Medicine at AIIMS Jammu

Union Budget 2025-26: Key Healthcare Measures for Cancer Care and Access to Life-Saving Drugs

FDA Approves Roche’s PATHWAY HER2 Test for Identifying HER2-Ultralow Breast Cancer Patients Eligible for ENHERTU

Bristol Myers Squibb’s Breyanzi® Receives CHMP Recommendation for Relapsed or Refractory Follicular Lymphoma in the EU

NHS to Offer Groundbreaking Gene Therapy for Sickle Cell Disease

Quibim Secures $50M Series A to Advance AI-Powered Imaging for Precision Medicine

Apollo Hospitals Unveils Advanced Oncology Facility in Chennai

Beckman Coulter’s Alzheimer’s Blood Test Receives FDA Breakthrough Device Designation

ANGLE Announces Breakthrough Dual CTC-DNA and ctDNA Analysis with Illumina’s NGS Solution

Diatech Pharmacogenetics and Merck Expand Collaboration to Enhance RAS Biomarker Testing in MEA Region

DCG Unveils AI-Powered Video-Reporting for Personalized Chemotherapy Selection

FDA Approves Monthly Maintenance Dosing for LEQEMBI® in Alzheimer’s Treatment

Home
/
update
/
details

DNAnexus and Oracle Collaborate to Integrate Products for Precision Health Data Analysis

NextEdge Admin

08 Apr 2024

2 min 0 sec

DNAnexus announced a partnership with Oracle on Wednesday, aimed at integrating their respective products for precision health data analysis. The financial terms of the deal were not disclosed. The collaboration entails making DNAnexus’ data management and analysis platform available to Oracle Cloud Infrastructure (OCI), Oracle Health, and Oracle Database customers. This integration extends to utilizing OCI’s integration services for healthcare applications.

The partnership seeks to leverage Oracle’s expertise in AI pipelines and industry partnerships to expedite genomic analyses and enhance AI models. DNAnexus is already utilizing OCI AI infrastructure for running genomic reports. DNAnexus CEO Thomas Laur expressed alignment between Oracle’s focus on rapid global cloud deployment and electronic health records with DNAnexus’ platform, enabling management, analysis, and collaboration on various data types.

Oracle’s Global AI Cloud Director, Dan Spellman, emphasized the collaboration’s potential in advancing personalized medicine and healthcare innovations. Oracle’s extensive ecosystem and global cloud presence across 69 regions complement DNAnexus’ proficiency in genomic data management and analysis.

DNAnexus, amid recent restructuring, has previously engaged in similar data analysis collaborations with entities like Curio Bioscience and TMA Precision Health. This latest partnership underscores the company’s commitment to facilitating advancements in precision health through strategic collaborations and leveraging complementary expertise.